Opaleye Management Inc. - May 17, 2024 Form 4 Insider Report for Protara Therapeutics, Inc. (TARA)

Role
10%+ Owner
Signature
Opaleye Management Inc., By: /s/ James Silverman, President
Stock symbol
TARA
Transactions as of
May 17, 2024
Transactions value $
-$230,326
Form type
4
Date filed
5/17/2024, 07:48 PM
Previous filing
May 10, 2024
Next filing
May 23, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TARA Common Stock, par value $0.001 per share Sale -$157K -47.3K -1.99% $3.33 2.33M May 17, 2024 By Opaleye, L.P. F1, F3
transaction TARA Common Stock, par value $0.001 per share Sale -$60.2K -19.7K -0.84% $3.06 2.31M May 17, 2024 By Opaleye, L.P. F1, F4
transaction TARA Common Stock, par value $0.001 per share Sale -$9.15K -2.75K -2.12% $3.33 127K May 17, 2024 By Managed account F2, F3
transaction TARA Common Stock, par value $0.001 per share Sale -$3.67K -1.2K -0.94% $3.06 126K May 17, 2024 By Managed account F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund.
F2 Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account.
F3 The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.01-$3.60 inclusive. The reporting person undertakes to provide,upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
F4 The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.00-$3.10 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.